ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, it looks like after next quarter's royalty payment that will be teh end of the royalties for Yescarta (not including the withholding tax assuming they win this issue).

10-Q

Based upon the events that led to the dismissal of the litigation between Cabaret and Kite, the Company does not expect to receive any future royalty income related to the Kite license agreement. In conjunction with
payment of amounts due to us, all outstanding litigation between the Company and Cabaret were dismissed.

In addition, the Israeli Tax Authority (the “ITA”) has taken the position that any payments from Cabaret to us are subject to mandatory withholding tax. The Company and its tax counsel have disputed this position and are actively seeking to resolve the issue. The ultimate outcome of this matter may impact the amount of cash due to us from various tax escrow accounts
that have been established.